Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Biofábrica Siglo XXI is a Mexican biotechnology company specializing in the development and commercialization of biofertilizers and plant growth-promoting microorganisms. Founded in 2003, the company utilizes mycorrhizal fungi and nitrogen-fixing bacteria to enhance agricultural productivity and restore soil health. Their product portfolio, including brands like Biosustenta and Azo-S, provides sustainable alternatives to synthetic chemical fertilizers by improving nutrient uptake and nitrogen fixation. The company operates specialized manufacturing facilities and maintains strong research collaborations with institutions like UNAM to advance agricultural biotechnology. Biofábrica Siglo XXI is a leader in the Mexican ag-biotech sector, focusing on reducing the environmental footprint of traditional farming while increasing crop yields.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Biofábrica Siglo.